📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Towards depersonalized abacavir therapy: chemical modification eliminates HLA-B*57 : 01-restricted CD8+ T-cell activation. (2015)

First Author: Naisbitt DJ

Attributed to: Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/qad.0000000000000867

PubMed Identifier: 26372480

Publication URI: http://europepmc.org/abstract/MED/26372480

Type: Journal Article/Review

Volume: 29

Parent Publication: AIDS (London, England)

Issue: 18

ISSN: 0269-9370